B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 26, 2011, Pages 10662-10667

  Schioppa, Tiziana ^a   Moore, Robert ^a   Thompson, Richard G ^a   Rosser, Elizabeth C ^b   Kulbe, Hagen ^a   Nedospasov, Sergei ^c,d   Mauri, Claudia ^b   Coussens, Lisa M ^e,f   Balkwill, Frances R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^d A Leibniz Institute   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Immune cells; Inflammation; Tumor microenvironment

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; GAMMA INTERFERON; INTERLEUKIN 10; TEREPHTHALIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SPLEEN; SQUAMOUS CARCINOGENESIS; TUMOR PROMOTION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADOPTIVE TRANSFER; ANIMALS; B-LYMPHOCYTES; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; SKIN NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 79960605654     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1100994108     Document Type: Article

References (33)

1. Moore R, et al. (1999) Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med 5:828-831. (Pubitemid 29318619)
2. Suganuma M, et al. (1999) Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res 59:4516-4518.
3. Pikarsky E, et al. (2004) NF-κB functions as a tumor promoter in inflammation-associated cancer. Nature 431:461-466. (Pubitemid 39329586)
4. Maeda S, Kamata H, Luo JL, Leffert H, Karin M (2005) IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121:977-990. (Pubitemid 40884391)
5. Kulbe H, et al. (2007) The inflammatory cytokine TNF-α generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 67:585-592. (Pubitemid 46192196)
6. Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9:361-371.
7. Popivanova BK, et al. (2008) Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 118:560-570. (Pubitemid 351206546)
8. Arnott CH, et al. (2004) Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development. Oncogene 23:1902-1910. (Pubitemid 38445416)
9. Hagemann T, et al. (2008) "Re-educating" tumor-associated macrophages by targeting NF-kappaB. J Exp Med 205:1261-1268. (Pubitemid 351831483)
10. Kim S, et al. (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457:102-106.
11. Charles KA, et al. (2009) The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest 119:3011-3023.
12. de Visser KE, Korets LV, Coussens LM (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7:411-423. (Pubitemid 40719125)
13. Andreu P, et al. (2010) FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 17:121-134.
14. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G (1996) Immune and inflammatory responses in TNF α-deficient mice: A critical requirement for TNF α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184:1397-1411. (Pubitemid 26354696)
15. Pasparakis M, et al. (1997) Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc Natl Acad Sci USA 94:6319-6323. (Pubitemid 27270682)
16. Kuprash DV, et al. (2005) Novel tumor necrosis factor-knockout mice that lack Peyer's patches. Eur J Immunol 35:1592-1600. (Pubitemid 40691439)
17. Grivennikov SI, et al. (2005) Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: Protective and deleterious effects. Immunity 22:93-104. (Pubitemid 40143454)
18. de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6:24-37. (Pubitemid 43053650)
19. Tan TT, Coussens LM (2007) Humoral immunity, inflammation and cancer. Curr Opin Immunol 19:209-216.
20. Su TT, Guo B, Wei B, Braun J, Rawlings DJ (2004) Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol Rev 197:161-178. (Pubitemid 38142175)
21. Mauri C, Ehrenstein MR (2008) The 'short' history of regulatory B cells. Trends Immunol 29:34-40.
22. Evans JG, et al. (2007) Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 178:7868-7878. (Pubitemid 46898059)
23. Bouaziz JD, Yanaba K, Tedder TF (2008) Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 224:201-214.
24. DiLillo DJ, Matsushita T, Tedder TF (2010) B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 1183:38-57.
25. Biswas SK, Mantovani A (2010) Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nat Immunol 11:889-896.
26. Ammirante M, Luo JL, Grivennikov S, Nedospasov S, Karin M (2010) B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464:302-305.
27. Brodt P, Gordon J (1978) Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor. J Immunol 121:359-362. (Pubitemid 8384890)
28. Inoue S, Leitner WW, Golding B, Scott D (2006) Inhibitory effects of B cells on antitumor immunity. Cancer Res 66:7741-7747. (Pubitemid 44289234)
29. Yusuf N, et al. (2008) Antagonistic roles of CD4+ and CD8+ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesis. Cancer Res 68:3924-3930.
30. Mauri C, Blair PA (2010) Regulatory B cells in autoimmunity: Developments and controversies. Nat Rev Rheumatol 6:636-643.
31. Coussens LM, Hanahan D, Arbeit JM (1996) Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am J Pathol 149:1899-1917. (Pubitemid 26415210)
32. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159. (Pubitemid 17064313)
33. Mauri C, Gray D, Mushtaq N, Londei M (2003) Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 197:489-501. (Pubitemid 36278604)